115 related articles for article (PubMed ID: 20126988)
1. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro.
Perchellet EM; Crow KR; Gakhar G; Nguyen TA; Shi A; Hua DH; Perchellet JP
Int J Oncol; 2010 Mar; 36(3):673-88. PubMed ID: 20126988
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of synthetic 6,7-annulated-4-substituted indole compounds in L1210 leukemic cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Thornton PD; Brown N; Hill D; Neuenswander B; Lushington GH; Santini C; Chandrasoma N; Buszek KR
Anticancer Res; 2012 Nov; 32(11):4671-84. PubMed ID: 23155229
[TBL] [Abstract][Full Text] [Related]
4. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
[TBL] [Abstract][Full Text] [Related]
5. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
[TBL] [Abstract][Full Text] [Related]
6. Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
Perchellet EM; Sperfslage BJ; Qabaja G; Jones GB; Perchellet JP
Anticancer Drugs; 2001 Jun; 12(5):401-17. PubMed ID: 11395569
[TBL] [Abstract][Full Text] [Related]
7. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.
Gakhar G; Hua DH; Nguyen TA
Anticancer Drugs; 2010 Jan; 21(1):77-88. PubMed ID: 19966541
[TBL] [Abstract][Full Text] [Related]
8. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
9. The effect of the PQ1 anti-breast cancer agent on normal tissues.
Ding Y; Prasain K; Nguyen TD; Hua DH; Nguyen TA
Anticancer Drugs; 2012 Oct; 23(9):897-905. PubMed ID: 22569107
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and proapoptotic activities of pyranoxanthenones, pyranothioxanthenones and their pyrazole-fused derivatives in HL-60 cells.
Perchellet EM; Ward MM; Skaltsounis AL; Kostakis IK; Pouli N; Marakos P; Perchellet JP
Anticancer Res; 2006; 26(4B):2791-804. PubMed ID: 16886598
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which synthetic 6,7-annulated-4-substituted indole compounds with anti-proliferative activity disrupt mitosis and block cytokinesis in human HL-60 tumor cells in vitro.
Perchellet JP; Perchellet EM; Singh CR; Monnett MT; Studer ER; Thornton PD; Brown N; Hill D; Neuenswander B; Lushington GH; Santini C; Buszek KR
Anticancer Res; 2014 Apr; 34(4):1643-55. PubMed ID: 24692693
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
13. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
[TBL] [Abstract][Full Text] [Related]
14. Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells.
Shishido SN; Nguyen TA
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840298
[TBL] [Abstract][Full Text] [Related]
15. PQ1, a quinoline derivative, induces apoptosis in T47D breast cancer cells through activation of caspase-8 and caspase-9.
Ding Y; Nguyen TA
Apoptosis; 2013 Sep; 18(9):1071-82. PubMed ID: 23677255
[TBL] [Abstract][Full Text] [Related]
16. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
Shishido SN; Delahaye A; Beck A; Nguyen TA
Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
Terry J; Lubieniecka JM; Kwan W; Liu S; Nielsen TO
Clin Cancer Res; 2005 Aug; 11(15):5631-8. PubMed ID: 16061882
[TBL] [Abstract][Full Text] [Related]
18. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
Newell SW; Perchellet EM; Ladesich JB; Freeman JA; Chen Y; Liu L; Hua DH; Kraft SL; Basaraba RJ; Perchellet JP
Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
